Infinity Pharmaceuticals Inc. (INFIQ)
OTCMKTS: INFIQ · Delayed Price · USD
0.00
0.00 (0.00%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Infinity Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Revenue
2.591.861.72
Revenue Growth (YoY)
39.56%8.09%-
Cost of Revenue
1.561.121.04
Gross Profit
1.030.740.68
Selling, General & Admin
13.4614.1712.42
Research & Development
32.4131.6526.76
Operating Expenses
45.8745.8239.18
Operating Income
-44.84-45.08-38.5
Interest Expense
0.180.182.45
Other Expense / Income
0.6600.45
Pretax Income
-44.37-45.26-40.49
Net Income
-44.37-45.26-40.49
Shares Outstanding (Basic)
898660
Shares Outstanding (Diluted)
898660
Shares Change
4.26%43.00%-
EPS (Basic)
-0.50-0.53-0.68
EPS (Diluted)
-0.50-0.53-0.68
Free Cash Flow
-42.45-40.63-35.78
Free Cash Flow Per Share
-0.48-0.47-0.60
Gross Margin
39.72%39.72%39.67%
Operating Margin
-1729.43%-2426.43%-2239.50%
Profit Margin
-1711.11%-2436.06%-2355.56%
Free Cash Flow Margin
-1637.02%-2186.71%-2081.56%
EBITDA
-44.39-44.6-38.01
EBITDA Margin
-1711.76%-2400.59%-2211.40%
Depreciation & Amortization
0.460.480.48
EBIT
-44.84-45.08-38.5
EBIT Margin
-1729.43%-2426.43%-2239.50%